EZR and ductal breast carcinoma in situ: There was a significant progressive increase in the percent of ezrin expression from the normal breast (mean ± SD of 67.05 ± 8.95, median of 70.0) to adjacent DCIS lesions (mean ± SD of 67.74 ± 8.25, median of 70.0) peaking in IBC-NST cases (mean ± SD of 79.25 ± 8.15, median of 80.0) (p < 0.001).